RESEARCHER PROFILE

Hend Attia

← Back to New Giza University

H

New Giza University

COVID-19 Clinical Research StudiesAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchDiabetes, Cardiovascular Risks, and LipoproteinsMicroRNA in disease regulation

Hend Attia works in COVID-19 Clinical Research Studies, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Diabetes, Cardiovascular Risks, and Lipoproteins, MicroRNA in disease regulation. Recorded institutional associations include New Giza University.

8Publications
33Citations
3H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. In vitro knock‐out of miR‐155 suppresses leukemic and HCV virus loads in pediatric HCV‐4–associated acute lymphoid leukemia: A promising target therapy

    2019 · 21 citations

  2. PRELIMINARY STUDY OF SCD14 AND SCD163 AS PREDICTORS OF DISEASE SEVERITY AND ICU ADMISSION IN COVID-19: RELATION TO HEMATOLOGICAL PARAMETERS, BLOOD MORPHOLOGICAL CHANGES AND INFLAMMATORY BIOMARKERS

    2023 · 7 citations

  3. Epigenetic alterations of miR-155 and global DNA methylation as potential mediators of ochratoxin A cytotoxicity and carcinogenicity in human lung fibroblasts

    2023 · 4 citations

  4. The study of the impact of additional chromosomal aberrations and c-MYC and BCR::ABL1 genes amplification on CML patient’s characteristics: relation to haematological parameters and patient outcome

    2023 · 1 citations

  5. An Approach to the Diagnosis of Paraproteinemia

    2022 · 0 citations

  6. Characteristics of TP53 mutation in adult precursor B-cell acute lymphoblastic leukemia

    2023 · 0 citations

  7. A single-center experience in home management of mild and moderate COVID-19 cases

    2024 · 0 citations

  8. FTO gene variants (rs17817449 and rs9939609) and novel leukocyte/Thrombocyte indexes as indicators of T2DM complications

    2025 · 0 citations

← Return to the university profile